logo

 

 

October 28, 2016

 

VIA EDGAR AND E-MAIL

United States Securities and Exchange Commission
Attention:     Suzanne Hayes, Assistant Director, Office of Healthcare and Insurance

Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010

 

Re:

Xenetic Biosciences, Inc.

Registration Statement on Form S-1

(File No. 333-211249)

   

 

 

 Ladies and Gentlemen:

 

We hereby request withdrawal of our previous request for acceleration of the above-referenced Registration Statement, which was dated October 26, 2016.

 

Thank you for your assistance in this matter.

 

Very truly yours,

 

Xenetic Biosciences, Inc.

 

By:  /s/ M. Scott Maguire                           

Michael Scott Maguire   

Chief Executive Officer

 

 

 

cc: David Strupp Ladenburg Thalmann & Co. Inc.
  Michael Maline Goodwin Procter LLP
  Mitchell D. Goldsmith Taft Stettinius & Hollister
  Jeremy Stonehill Taft Stettinius & Hollister